Feb 18, 2014
A Yale Innovation Fund Backs New Antacid Called Tummyzen With $100,000
Heartburn sufferers: Some Ivy League relief is on the way.
Over last weekend, a local startup company called Eli Nutrition put a small batch of its new antacid, Tummyzen, up for sale on Amazon. The product is based on research by Dr. John Geibel of the Yale School of Medicine.
More of the product will be on the way soon, thanks to a $100,000 investment announced Monday by the Yale Entrepreneurial Institute. It is the first $100,000 investment by YEI’s Innovation Fund.
Hasan Ansari, a co-founder of Eli Nutrition and a Yale School of Management student, said the injection of money will allow the company to produce a full batch of 10,000 bottles of Tummyzen and develop a marketing campaign.
Tummyzen retails for $14.99 for a bottle of 40 tablets.
“We think this dietary supplement holds the answer for a vast number of Americans who are taking much harsher medications,” Ansari said.